Paper Review Records
全部论文审稿周期
27 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
142
天
Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a
作者
Anne Sophie V. M. Van den Heerik; Cathalijne C. B. Post; Marie A. D. Haverkort; Nienke Kuijsters; Stefan Kommoss; Friederike L. A. Koppe; Marlies E. Nowee; Henrike Westerveld; Maria A. A. De Jong; Filip Frühauf; Jeltsje S. Cnossen; Jan Willem M. Mens; Jannet C. Beukema; Cyrus Chargari; Charles Gillham; Dorine S. J. Tseng; Katrien Vandecasteele; Karen Verhoeven-Adema; Hans W. Nijman; Remi A. Nout; Bastiaan G. Wortman; Stephanie M. De Boer; Hein Putter; Vincent T. H. B. M Smit; Carien L. Creutzberg; Nanda Horeweg展开收起
作者单位
1. Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands; 2. Department of Radiation Oncology, Radiotherapiegroep, Arnhem, The Netherlands; 3. Maastro, Maastricht, The Netherlands; 4. Department of Women’s Health, Tübingen University Hospital, Tübingen and Diak Klinikum, Department of Gynecology & Obstetrics, Schwaebisch Hall, Germany; 5. Institute Verbeeten, Tilburg, The Netherlands; 6. Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands; 7. Department of Radiation Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands; 8. Department of Radiotherapy, Erasmus MC – Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; 9. Radiotherapeutisch Instituut Friesland, Leeuwarden, The Netherlands; 10. Department of Gynaecology, Obstetrics and Neonatology, General University Hospital Prague, First Medical Faculty of the Charles University, Prague, Czech Republic; 11. Department of Radiotherapy, Catharina Hospital Eindhoven, Eindhoven, The Netherlands; 12. Department of Radiotherapy, University Medical Center Groningen, Groningen, The Netherlands; 13. Department of Radiotherapy, Institut Gustave Roussy, Villejuif, France; 14. Department of Radiation Oncology, St. Luke’s Hospital, Dublin, Ireland and Cancer Trials, Dublin, Ireland; 15. Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; 16. Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium; 17. Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; 18. Department of Gynecology, University Medical Center Groningen, Groningen, The Netherlands; 19. Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands; 20. Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands展开收起
184
天
Long-term fatigue dimensions in the Multidimensional Fatigue Inventory (MFI) up to five years after radiotherapy and their trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study
作者
Philipp Heumann; Juan C. Rosas; Miguel E. Aguado-Barrera; David Azria; Axel Benner; Erik Briers; Renée Bultijnck; Ananya Choudhury; Antonio Gómez-Caamaño; Rudolf Kaaks; Maarten Lambrecht; Tiziana Rancati; Barry S. Rosenstein; Dirk De Ruysscher; Martina E. Schmidt; Susanne Singer; Elena Sperk; Hilary Stobart; Ana Vega; Liv Veldeman; Tim Ward; Adam Webb; Catharine M. West; Jenny Chang-Claude; Christopher J. Talbot; Tim Rattay; Petra Seibold展开收起
作者单位
1. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 2. Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany; 3. Fundación Pública Galega de Medicina Xenómica (FPGMX), Servicio Galego de Saúde, Santiago de Compostela, Spain; 4. Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain; 5. ICM Institut du Cancer Montpellier, Montpellier, France; 6. Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7. Ghent University Hospital, Ghent, Belgium; 8. Department of Human Structure and Repair, Ghent University, Ghent, Belgium; 9. University of Manchester, Christie Hospital NHS Foundation Trust, Manchester, UK; 10. Department of Radiation Oncology, Hospital Clínico Universitario de Santiago de Compostela, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain; 11. UZ Leuven, Leuven, Belgium; 12. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 13. Icahn School of Medicine at Mount Sinai, New York, USA; 14. MAASTRO Clinic, Maastricht, Netherlands; 15. Division of Physical Activity, Cancer Prevention and Survivorship, German Cancer Research Center (DKFZ), Heidelberg, Germany; 16. Comprehensive Cancer Center Mecklenburg Vorpommern, University Medical Center Rostock, Rostock, Germany; 17. Mannheim Cancer Center, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; 18. Biomedical Network on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Santiago de Compostela, Spain; 19. University of Leicester, Leicester, UK; 20. The University of Manchester, Manchester, UK; 21. Division of Personalized Early Detection of Prostate Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany展开收起
199
天
SKP2-mediated CDK4 selective degradation contributes to SCP-7e-induced cell death of non-small cell lung cancer
作者
Qiulin Yan; Hui Ren; Haiying Xu; Xuehan Ma; Yuanqing Li; Qiurong Liu; Yi Yang; Qingbo Liu; Guo-Dong Yao; Shao-Jiang Song展开收起
作者单位
1. Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research & Development, Liaoning Province; Engineering Research Center of Natural Medicine Active Molecule Research & Development, Liaoning Province; Key Laboratory of Natural Bioactive Compounds Discovery & Modification, Shenyang; School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, China; 2. Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China; 3. Liaoning University of Traditional Chinese Medicine, Shenyang, China展开收起
319
天
Which is more effective at improving uptake of bowel cancer screening: text message reminders or patient navigation? Results from a three-arm RCT
作者
Benzeer Siddique; Thomas Duffy; Natalie Gil; Andrew Prentice; Sarah Marshall; Natasha Djedovic; Abhinav Sundriyal; Michael Lewis; Josephine Ruwende; Ghalia Kayal; Aradhna Kaushal; Yasemin Hirst; Stephen Duffy; Christian von Wagner; Robert S. Kerrison展开收起
作者单位
1. Department of Behavioural Science and Health, University College London, London, UK; 2. St Mark’s Bowel Cancer Screening Centre, Harrow, UK; 3. Centre for Evaluation and Methods, Wolfson Institute of Population Health, Queen Mary University of London, London, UK; 4. School of Health Sciences, University of Surrey, Surrey, UK; 5. St Mark’s Hospital, Harrow, UK; 6. University of Birmingham, Birmingham, UK; 7. NHS England (London), London, UK; 8. Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; 9. Applied Health Research Hub, University of Lancashire, Lancashire, Preston, UK; 10. Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, UK展开收起
211
天
Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study
作者
Philipp Heumann; Juan C. Rosas; Miguel E. Aguado-Barrera; David Azria; Axel Benner; Erik Briers; Renée Bultijnck; Ananya Choudhury; Antonio Gómez-Caamaño; Rudolf Kaaks; Maarten Lambrecht; Tiziana Rancati; Barry S. Rosenstein; Dirk De Ruysscher; Martina E. Schmidt; Susanne Singer; Elena Sperk; Hilary Stobart; Ana Vega; Liv Veldeman; Tim Ward; Adam Webb; Catharine M. West; Jenny Chang-Claude; Christopher J. Talbot; Tim Rattay; Petra Seibold展开收起
作者单位
1. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 2. Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany; 3. Fundación Pública Galega de Medicina Xenómica (FPGMX), Servicio Galego de Saúde, Santiago de Compostela, Spain; 4. Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain; 5. ICM Institut du Cancer Montpellier, Montpellier, France; 6. Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany; 7. Ghent University Hospital, Ghent, Belgium; 8. Department of Human Structure and Repair, Ghent University, Ghent, Belgium; 9. University of Manchester, Christie Hospital NHS Foundation Trust, Manchester, United Kingdom; 10. Department of Radiation Oncology, Hospital Clínico Universitario de Santiago de Compostela, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain; 11. UZ Leuven, Leuven, Belgium; 12. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 13. Icahn School of Medicine at Mount Sinai, New York, USA; 14. MAASTRO Clinic, Maastricht, Netherlands; 15. Division of Physical Activity, Cancer Prevention and Survivorship, German Cancer Research Center (DKFZ), Heidelberg, Germany; 16. Comprehensive Cancer Center Mecklenburg Vorpommern, University Medical Center Rostock, Rostock, Germany; 17. Mannheim Cancer Center, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; 18. Biomedical Network on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Santiago de Compostela, Spain; 19. University of Leicester, Leicester, United Kingdom; 20. The University of Manchester, Manchester, United Kingdom; 21. Division of Personalized Early Detection of Prostate Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany展开收起
50
天
Efflux transporter biomarkers and treatment sequencing in parp inhibitor resistance
作者
Yuquan Yuan; Chengzhi Zhao展开收起
作者单位
1. Department of Obstetrics and Gynecology, Chongqing Health Center for Women and Children, Chongqing, China; 2. Department of Obstetrics and Gynecology, Women and Children’s Hospital of Chongqing Medical University, Chongqing, China; 3. Chongqing Key Laboratory of Human Embryo Engineering and Precision Medicine, Chongqing, China展开收起
FAQ
BRITISH JOURNAL OF CANCER审稿要多久?
截至2026-11-18,CrushSCI 收录了 BRITISH JOURNAL OF CANCER 的 27 篇完整审稿记录。最快一篇从收稿到录用用了 29 天(Oligometastatic neuroendocrine tumours: imprecision is not equivalence,2026-07-21 收稿,2026-08-19 录用),最慢一篇用了 350 天;平均 169.6 天,中位数 163 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
